Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00075556
What this trial is testing

Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Large-scale testing (Phase 3)Study completedNCT00003873
What this trial is testing

Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 950
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT00556413
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 42
Testing effectiveness (Phase 2)Study completedNCT03365882
What this trial is testing

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colon AdenocarcinomaERBB2 Gene AmplificationRectal Adenocarcinoma+16 more
SWOG Cancer Research Network 240
Testing effectiveness (Phase 2)Ended earlyNCT01729923
What this trial is testing

A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon Cancer+3 more
University of Washington 27
Early research (Phase 1)Ended earlyNCT06882746
What this trial is testing

Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

Who this might be right for
Colorectal CarcinomaGastric CarcinomaPancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 14
Large-scale testing (Phase 3)Ended earlyNCT00499369
What this trial is testing

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 72
Early research (Phase 1)Study completedNCT00028405
What this trial is testing

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Who this might be right for
Liver MetastasisPelvic CancerHead and Neck Cancer+5 more
Light Sciences LLC 48
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Not applicableNot Yet RecruitingNCT07780305
What this trial is testing

ABCSG R07 Rectal Cancer Registry

Who this might be right for
Rectal CancerAdenocarcinoma of Rectum
Austrian Breast & Colorectal Cancer Study Group 600
Early research (Phase 1)UnknownNCT00895323
What this trial is testing

Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 9
Large-scale testing (Phase 3)Ended earlyNCT01189227
What this trial is testing

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
NSABP Foundation Inc 9
Not applicableStudy completedNCT01977053
What this trial is testing

Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients

Who this might be right for
Non-metastatic Patients With Breast CancerNon-metastatic Patients With Colon CancerNon-metastatic Patients With Rectal Cancer+1 more
Centre Antoine Lacassagne 274
Not applicableEnded earlyNCT01280643
What this trial is testing

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fox Chase Cancer Center 3
Early research (Phase 1)WithdrawnNCT00780988
What this trial is testing

Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsAnal, Colon, and Rectal Cancers
Stanford University
Not applicableEnded earlyNCT01867918
What this trial is testing

LOTCOL Study: Local Treatment of Colo-rectal Liver Met

Who this might be right for
Metastatic Colo-rectal Cancer
Oslo University Hospital 3
Not applicableLooking for participantsNCT03587480
What this trial is testing

Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy

Who this might be right for
Rectal Neoplasm Malignant
Sixth Affiliated Hospital, Sun Yat-sen University 250
Early research (Phase 1)Study completedNCT01158274
What this trial is testing

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT06491355
What this trial is testing

First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Efficacy, SelfSafety IssuesColo-rectal Cancer
Sir Run Run Shaw Hospital 72
Next Page